Quantifying Co-Oligomer Formation by α-Synuclein

ACS Nano. 2018 Nov 27;12(11):10855-10866. doi: 10.1021/acsnano.8b03575. Epub 2018 Oct 29.

Abstract

Small oligomers of the protein α-synuclein (αS) are highly cytotoxic species associated with Parkinson's disease (PD). In addition, αS can form co-aggregates with its mutational variants and with other proteins such as amyloid-β (Aβ) and tau, which are implicated in Alzheimer's disease. The processes of self-oligomerization and co-oligomerization of αS are, however, challenging to study quantitatively. Here, we have utilized single-molecule techniques to measure the equilibrium populations of oligomers formed in vitro by mixtures of wild-type αS with its mutational variants and with Aβ40, Aβ42, and a fragment of tau. Using a statistical mechanical model, we find that co-oligomer formation is generally more favorable than self-oligomer formation at equilibrium. Furthermore, self-oligomers more potently disrupt lipid membranes than do co-oligomers. However, this difference is sometimes outweighed by the greater formation propensity of co-oligomers when multiple proteins coexist. Our results suggest that co-oligomer formation may be important in PD and related neurodegenerative diseases.

Keywords: cross-aggregation; mixed oligomers; neurodegeneration; oligomer toxicity; single-molecule fluorescence; statistical mechanical modeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / biosynthesis*
  • Amyloid beta-Peptides / chemistry
  • Humans
  • Models, Molecular
  • Thermodynamics
  • alpha-Synuclein / chemistry
  • alpha-Synuclein / metabolism*
  • tau Proteins / biosynthesis*
  • tau Proteins / chemistry

Substances

  • Amyloid beta-Peptides
  • MAPT protein, human
  • alpha-Synuclein
  • tau Proteins